Meet IAG’ Research Team at OARSI to Discuss Osteoarthritis Clinical Research

Slider with alias news slider not found.

Meet IAG’ Research Team at OARSI to Discuss Osteoarthritis Clinical Research

Meet IA’s musculoskeletal experts at the World Congress on Osteoarthritis in Las Vegas, NV, April 27-30, 2017, where they will be speaking about their work in osteoarthritis clinical research.

Dr. John Carrino, member of IA’s Clinical Advisory Board will speak at 12:00 on 30 April in a Plenary Session ‘Year in Review’ and give an overview of imaging in Osteoarthritis clinical practice and research.

The Chair of IAG’s Clinical Advisory Board Dr. Mikael Boesen will present a paper linking the exercise and pain reductions in knee osteoarthritis. His presentation ‘Exercise-Induced Pain Reductions in Knee OA are Associated with Changes in Muscle Perfusion Quantified by Dynamic Contrast Enhanced MRI: Exploratory Outcome Analysis from a Randomized Controlled Trial’ is scheduled to start at 4:40pm on Saturday, 29 April.

Other collaborators of IAG from the Parker Institute, Nordic Bioscience, BICL and Boston University will be attending OARSI, which brings together the top researchers, investigators and investors trying to find cure for osteoarthritis.

About Osteoarthritis

Osteoarthritis is a degenerative joint disease and the most common disorder in the world. It is a result of a complex interplay of multiple factors, including joint integrity, genetic predisposition, local inflammation, mechanical forces and cellular and biochemical processes. There is no cure for OA at the moment.

About Image Analysis Group (IAG)

IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner.  IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.

Learn more:

Reach out:

Follow the Company: Linkedin